Allopurinol treatment in pediatric multiple sclerosis

Yousef A Assaleh,Farah Thabet, Kalthoum Graies-Tlili,Brahim Tabarki

Neuroimmunology Reports（2024）

引用 0|浏览1

暂无评分

摘要

We report a 12-year-old male patient with relapsing-remitting multiple sclerosis who showed a strong response to allopurinol with no safety concern. Researchers should further evaluate this drug option in multiple sclerosis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要